Omicron News and Research

RSS

A test to identify antibody effectiveness against COVID-19 variants

Since the start of the COVID-19 pandemic, variants have begun to emerge. We spoke to Jacob Heggestad about his rapid test that can detect these variants.

20 Dec 2021

Study suggests SARS-CoV-2 Omicron variant RBM binding may be weaker than in wild-type

A new study shows that the Omicron variant binds to the ACE2 receptor in a significantly weaker manner than other variants and the wild-type.

20 Dec 2021

Vaccine promoters struggle to get people boosted in California’s fields

Since the start of the pandemic, Luz Gallegos and her team of 56 advocates for immigrants have battled the scorching sun, illiteracy and deadly propaganda in the fields and fruit groves of the Coachella Valley.

20 Dec 2021

The vaccine rollout was a success. But events within and beyond Biden’s control stymied progress.

Eleven months ago, President Joe Biden assumed office during one of the most critical moments of the covid-19 pandemic. Case counts and death rates were shockingly high.

20 Dec 2021

Impact of SARS-CoV-2 variants in unvaccinated and vaccinated U.S. military personnel

A new study helps to explain the rapid spread of the Delta variant and provides the impetus to increase control measures including vaccine boosters and social distancing requirements.

20 Dec 2021

CRISPR-based microfluidic platform detects respiratory viruses and SARS-CoV-2 variants

Researchers in the US have developed a novel multiplexed diagnostic platform based on CRISPR-based approaches and microfluidics - enabling robust and simultaneous surveillance of multiple viruses and viral variants. Currently, the paper is available on the medRxiv* preprint server pending peer review.

19 Dec 2021

Production of functional SARS-CoV-2 spike protein in single-cell green alga

A new study uses a novel algal platform for the generation of the SARS-CoV-2 spike protein.

19 Dec 2021

More than 50% of the adult UK population boosted against COVID-19

More than 50% of the adult UK population are now boosted after the programme was accelerated this week to offer the jab to everyone aged over 18.

17 Dec 2021

Government provides record funding to support the social care sector

Care providers, residents and staff will all benefit from additional funding to support the social care sector.

17 Dec 2021

Government and faith leaders unite in the national effort to urge booster uptake

The government and faith leaders have united in the national effort to get the country boosted in the wake of a surge in Omicron cases.

17 Dec 2021

Simulating transmission dynamics of SARS-CoV-2 Omicron variant

Researchers simulated the emergence of Omicron, a novel SARS-CoV-2 VOC, in a general European setting using an individual-based transmission model.

17 Dec 2021

Predicting local surges of COVID-19 hospitalizations in 2022

Researchers have identified simple and easy-to-communicate decision rules to provide early warnings - when a pre-specified threshold of hospital capacity will likely be exceeded within a four or eight week period.

17 Dec 2021

Vaccine effectiveness against COVID-19 caused by Omicron and Delta SARS-CoV-2 variants in England

Researchers performed a test-negative case-control study to determine the effectiveness of BNT162b2 and ChAdOx1 COVID-19 vaccines against the Omicron and Delta variants of SARS-CoV-2.

17 Dec 2021

Impact of SARS-CoV-2 Omicron mutations on the use of therapeutic antibodies in COVID-19 treatment

Researchers investigated the mutations reported in the Omicron variant and its likely impact on the use of therapeutic antibodies in COVID-19 treatment as well as on vaccinated individuals.

17 Dec 2021

R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislation

R-Biopharm announces that the company’s RIDA®GENE Flu & SARS-CoV-2 multiplex test (PG6825) has been approved in the UK under the UK Health Security Agency’s Medical Devices (Coronavirus Test Device Approvals) Regulations 2021 (“CTDA”).

17 Dec 2021

Prediction of waning COVID-19 vaccine efficacy against Omicron variant

Researchers performed a meta-analysis of the results of four previous studies estimating fold-drop in neutralization titer against Omicron to present a combined estimate of the same.

17 Dec 2021

Analysis of the alteration of neutralizing titers with Omicron pseudovirus

A new study measured antibody levels from blood samples of vaccinated individuals and individuals who recovered from COVID-19 illness.

17 Dec 2021

Comparison of RBD/ACE2 receptor complex in wild type SARS-CoV-2 and Omicron variant

New research details the molecular landscape of Omicron’s RBD and how it differs from the original SARS-CoV-2 strain.

17 Dec 2021

25 million people in the UK have had COVID-19 top up jab

More than 25 million people in the UK have had a COVID-19 top up jab, as the vaccination programme is turbocharged to get all eligible adults boosted as soon as possible.

16 Dec 2021

G7 health ministers issue statement on the global threat of Omicron variant

G7 health ministers today held their final meeting of the UK's G7 Presidency, focusing particularly on the very worrying developments on Omicron.

16 Dec 2021

Omicron News and Research

A test to identify antibody effectiveness against COVID-19 variants

Study suggests SARS-CoV-2 Omicron variant RBM binding may be weaker than in wild-type

Vaccine promoters struggle to get people boosted in California’s fields

The vaccine rollout was a success. But events within and beyond Biden’s control stymied progress.

Impact of SARS-CoV-2 variants in unvaccinated and vaccinated U.S. military personnel

CRISPR-based microfluidic platform detects respiratory viruses and SARS-CoV-2 variants

Production of functional SARS-CoV-2 spike protein in single-cell green alga

More than 50% of the adult UK population boosted against COVID-19

Government provides record funding to support the social care sector

Government and faith leaders unite in the national effort to urge booster uptake

Simulating transmission dynamics of SARS-CoV-2 Omicron variant

Predicting local surges of COVID-19 hospitalizations in 2022

Vaccine effectiveness against COVID-19 caused by Omicron and Delta SARS-CoV-2 variants in England

Impact of SARS-CoV-2 Omicron mutations on the use of therapeutic antibodies in COVID-19 treatment

R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislation

Prediction of waning COVID-19 vaccine efficacy against Omicron variant

Analysis of the alteration of neutralizing titers with Omicron pseudovirus

Comparison of RBD/ACE2 receptor complex in wild type SARS-CoV-2 and Omicron variant

25 million people in the UK have had COVID-19 top up jab

G7 health ministers issue statement on the global threat of Omicron variant

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News